Abstract
In this study, the novel germatrane compound, 3-(2, 8, 9-trioxa-5-aza-1- germatricyclo [3.3.3.0] undecane-1- yl)-3-(4-hydroxy-3- methoxyphenyl)-propionic acid (1), has been synthesized and its activities against cervical tumor U14 were evaluated in vitro and in vivo. The results have demonstrated that the compound posed significant inhibition on U14 tumor with IC50 values of 48.57 mg/L in cell-based assay and tumor inhibitory rates of 38.50 %, 47.17 % and 64.02 % (from low dose to high dose) in animal experiment.
Keywords: Germanium, ferulic acid, synthesis, trichlorogermane, germatrane, 3-(2, 8, 9-trioxa-5-aza-1-germatricyclo [3. 3. 3.0] undecane-1-yl)-3-(4-hydroxy-3- methoxyphenyl)-propionic acid, U14 tumor, antitumor activity, inhibitory rate, germatrane compound
Medicinal Chemistry
Title:Synthesis of 3-(2, 8, 9-trioxa-5-aza-1-germatricyclo [3.3.3.0] Undecane-1- yl)-3-(4-hydroxyl-3-methoxyphenyl)-propionic Acid and its Inhibitory Effect on the Cervical Tumor U14 in vitro and in vivo
Volume: 8 Issue: 4
Author(s): Lianbao Ye, Xiaomin Ou, Xuedong Peng and Yan Luo
Affiliation:
Keywords: Germanium, ferulic acid, synthesis, trichlorogermane, germatrane, 3-(2, 8, 9-trioxa-5-aza-1-germatricyclo [3. 3. 3.0] undecane-1-yl)-3-(4-hydroxy-3- methoxyphenyl)-propionic acid, U14 tumor, antitumor activity, inhibitory rate, germatrane compound
Abstract: In this study, the novel germatrane compound, 3-(2, 8, 9-trioxa-5-aza-1- germatricyclo [3.3.3.0] undecane-1- yl)-3-(4-hydroxy-3- methoxyphenyl)-propionic acid (1), has been synthesized and its activities against cervical tumor U14 were evaluated in vitro and in vivo. The results have demonstrated that the compound posed significant inhibition on U14 tumor with IC50 values of 48.57 mg/L in cell-based assay and tumor inhibitory rates of 38.50 %, 47.17 % and 64.02 % (from low dose to high dose) in animal experiment.
Export Options
About this article
Cite this article as:
Ye Lianbao, Ou Xiaomin, Peng Xuedong and Luo Yan, Synthesis of 3-(2, 8, 9-trioxa-5-aza-1-germatricyclo [3.3.3.0] Undecane-1- yl)-3-(4-hydroxyl-3-methoxyphenyl)-propionic Acid and its Inhibitory Effect on the Cervical Tumor U14 in vitro and in vivo, Medicinal Chemistry 2012; 8 (4) . https://dx.doi.org/10.2174/157340612801216157
DOI https://dx.doi.org/10.2174/157340612801216157 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nontraditional Cardiovascular Risk Factors in Pediatric Type 1 Diabetes
Current Diabetes Reviews Role of Sensory Neurons in Restitution and Healing of Gastric Ulcers
Current Pharmaceutical Design L-Arginine Analogs – Inactive Markers or Active Agents in Atherogenesis?
Cardiovascular & Hematological Agents in Medicinal Chemistry Withdrawn: Mesenchymal Stem Cell-derived Exosomes for Treatment of Ischemic Stroke
Current Stem Cell Research & Therapy Investigating Drug Repositioning Approach to Design Novel Prodrugs for Colon-specific Release of Fexofenadine for Ulcerative Colitis
Current Drug Delivery 19F: A Versatile Reporter for Non-Invasive Physiology and Pharmacology Using Magnetic Resonance
Current Medicinal Chemistry Protective Effects of Anesthetics on Vascular Function Related to K<sup>+</sup> Channels
Current Pharmaceutical Design Pharmacological Treatment of Obstructive Sleep Apnea
Current Pharmaceutical Design Mast Cells: Target and Source of Neuropeptides
Current Pharmaceutical Design Role of Adiponectin in Obesity, Hypertension, and Metabolic Syndrome
Current Hypertension Reviews The IL23/Th17 Pathway as a Therapeutic Target in Chronic Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Development of Nanocomponent Ointment Composition for the Treatment of Various Etiologies Wounds
Current Nanomedicine Clinical Applications of Transcranial Doppler Sonography
Reviews on Recent Clinical Trials Evaluation of the Potential of Brazilian Red Propolis in the Acceleration of Healing in Surgical Wounds
The Natural Products Journal The anti-inflammatory agents Siblings Nitroxyl (HNO) and Nitric Oxide (NO) in Cardioprotection
Drug Design Reviews - Online (Discontinued) Statins and Portal Hypertension: A New Pharmacological Challenge
Current Vascular Pharmacology Anti-platelet Drug-loaded Targeted Technologies for the Effective Treatment of Atherothrombosis
Current Drug Targets Olive Oil and Haemostasis
Current Nutrition & Food Science Hypertension and Endothelial Dysfunction: Therapeutic Approach
Current Vascular Pharmacology PET Radioligands for In Vivo Visualization of Neuroinflammation
Current Pharmaceutical Design